<p>Indian drugmaker Shilpa Medicare Limited said on Friday it had agreed to produce and supply Cadila Healthcare Ltd's three-dose Covid-19 vaccine.</p>.<p>The country's health authorities had given emergency approval in August for Cadila's vaccine, the world's first Covid-19 DNA shot, in adults and children aged 12 years and above.</p>.<p>Shilpa Medicare said its unit will make the vaccine's drug substance, while Cadila will package, distribute and market the shot.</p>.<p>Cadila Healthcare and Shilpa Medicare did not immediately respond to Reuters' requests seeking details on the deal. </p>.<p><strong>Check out the DH videos here:</strong><br /> </p>
<p>Indian drugmaker Shilpa Medicare Limited said on Friday it had agreed to produce and supply Cadila Healthcare Ltd's three-dose Covid-19 vaccine.</p>.<p>The country's health authorities had given emergency approval in August for Cadila's vaccine, the world's first Covid-19 DNA shot, in adults and children aged 12 years and above.</p>.<p>Shilpa Medicare said its unit will make the vaccine's drug substance, while Cadila will package, distribute and market the shot.</p>.<p>Cadila Healthcare and Shilpa Medicare did not immediately respond to Reuters' requests seeking details on the deal. </p>.<p><strong>Check out the DH videos here:</strong><br /> </p>